Additionally, a significant decrease in the percentage of cyclin-D3-expressing JVM-13 cells after treatment with IBS (2 μg/mL), and with both tested concentrations of MBS, was noticed (Figure 4d). Here, CCND3 is linked to irritable bowel syndrome.